baber/WOPTO huggingface dataset:
Patent DE-03730668-T1 (DE)
Title: Sprachsignalinterpolationseinrichtung
Inventor: SATO YASUSHI
IPC: G10L25/90
Filed: 2003-05-28
Abstract: Sprachsignalinterpolationsvorrichtung,
umfassend:  ein Tonhöhenwellenformsignalerzeugungsmittel
zum Erfassen eines Spracheingabesignals, das für eine Sprach-Wellenform repräsentativ
ist, und im Wesentlichen Angleichen einer Zeitdauer eines Abschnitts,
der einer Tonhöheneinheit
des Spracheingabesignals entspricht, um das Spracheingabesignal
in ein Tonhöhenwellenformsignal
umzuwandeln;  ein Spektrumableitungsmittel zum Erzeugen von
Daten, die für
ein Spektrum des Spracheingabesignals repräsentativ sind, gemäß dem Tonhöhenwellenformsignal;  ein
Mittelwertbildungsmittel zum Erzeugen von Bemittelten Daten, die
für ein
Spektrum einer Verteilung von Durchschnittswerten jeweiliger Spektrumkomponenten
des Spracheingabesignals repräsentativ
sind, gemäß mehreren
Datenteilstücken,
die von dem Spektrumableitungsmittel erzeugt wurden; und  ein
Sprachsignalwiederherstellungsmittel zum Erzeugen eines Sprachausgabesignals,
das für
Sprache repräsentativ
ist, die ein Spektrum aufweist, das durch die gemittelten Daten
repräsentiert
wird, welche durch das Mittelwertbildungsmittel erzeugt wurden.
Patent DE-10196426-T1 (DE)
Inventor: GERVAIS ERIC
IPC: A61K9/20
Filed: 2001-06-21
Abstract: A new enterically-coated pyridoxine HCl and doxylamine succinate (DS-P) rapid onset formulation comprises disintegrating agent. The formulation has a dissolution profile of at least 40%, 70%, 80% and 90% after 30, 60, 90 and 120 minutes respectively when measured in 1000 ml phosphate buffer at pH 6.8 and 37[deg]C in a type 2 dissolution apparatus at 100 revolutions per minute (rpm). ACTIVITY : Antiemetic. No biological data given. MECHANISM OF ACTION : None given.
Patent DE-46511-T1 (DE)
IPC: B23B27/16
Filed: 1981-07-22
Abstract: A cutting insert with indexable cutting edges with a chip-breaker configuration which comprises discrete recesses spaced along the length of the cutting insert. The cutting insert has a descending wall that joins the cutting edge or the land behind the cutting edge with a planar floor that extends toward the center of the insert. The recesses are formed in the descending wall adjacent the cutting edge or land behind the cutting edge and are concave facing outwardly as they extend inwardly of the insert. The inserts are coated, preferably with a TiN over TiC chemical vapor deposition coating.
Patent DE-794126-T1 (DE)
Inventor: BROWN PAUL EDWARD
IPC: B65D83/00
Filed: 1992-12-02
Abstract: A dispensing valve (3) for fluid product packaging comprising: a flange (4); a valve head (5) having a marginal edge (42) and interior and exterior sides (39, 38) and an orifice (6); a resiliently flexible sleeve (7), with one end portion (50) thereof connected with the flange (4), and an opposite head end portion (49) thereof connected with said head (5) adjacent the marginal edge thereof. When pressure is applied to the head the sleeve has a doubled over rolling exterior rim (65) which rolls along the sleeve to be at the head end portion (49) of the sleeve when the sleeve is in a fully extended configuration thereof in which the orifice is closed, forces applied thereafter to the head by the sleeve and pressure in excess of the predetermined discharge pressure causing an unrolling of the doubled over rim (65) as the orifice (6) opens. The valve quickly and accurately achieves a balance between container, valve and fluid product. <IMAGE>
Patent ES-2734682-T1 (ES)
Title: Sistema de monitorización de salud de protocolo de dispositivo móvil
Inventor: PARTHENIOU ANTHONIOS
IPC: H04W24/08
Filed: 2015-03-26
Abstract: Un método de monitorización de salud de protocolo en una red de dispositivos móviles (17, 18) que comprende: un proceso de determinación de un umbral de la velocidad de transmisión de mensajes para establecer una dirección de bloqueo y al menos un umbral de velocidad de transmisión máxima asociada con el mismo para dicha red de dispositivos móviles (17, 18), monitorizar una velocidad de transmisión de mensajes asociada con dicha dirección de bloqueo en dicha red de dispositivos móviles (17, 18), comparar un rango de dicha velocidad de transmisión con el al menos un umbral de velocidad de transmisión máxima y registrar una indicación de salud de protocolo cuando dicha velocidad de transmisión está dentro de dicho rango.
Patent ES-2047468-T1 (ES)
Title: Accionamiento lineal para un tensor de cinturon.
Inventor: FOHL ARTUR
IPC: B60R22/18
Filed: 1993-05-05
Abstract: EL ACCIONAMIENTO LINEAL PARA UN TENSADOR DE CINTURON EN UN SISTEMA DE CINTURON DE SEGURIDAD DE VEHICULO SE CARACTERIZA POR MEDIO DE UNA FORMA DE CONSTRUCCION ESBELTA, EXTENDIDA Y APROPIADA PARA SU DISPOSICION EN LA DIRECCION LONGITUDINAL DEL VEHICULO. EL GENERADOR (20) DE GAS ESTA PREVISTO CON SU DISPARADOR DE PERCUSION, ACCIONANDO CONJUNTAMENTE CON UNA PIEZA (32) DE PERCUSION CARGADA ELASTICAMENTE. ESTA PIEZA (32) ESTA SUJETA A TRAVES DE UN DISPOSITIVO (48) DE RETENCION EN SU POSICION DE REPOSO. POR MEDIO DE UNA MASA SENSOR (26) DESPLAZABLE EN UNA CAJA (12) PUEDE SER LEVANTADA LA RETENCION, Y QUEDAR LIBRE LA PIEZA (32) DE PERCUSION. LA CAJA, EN DONDE TAMBIEN ESTA DISPUESTA EL GENERADOR (20) DE GAS, DESCANSA EN EL ALARGAMIENTO DEL CILINDRO (10) Y ESTA UNIDO CON EL E FORMA FIJA. LA MASA SENSOR (26) Y LA PIEZA (32) DE PERCUSION SON MOVIBLE DE FORMA PARALELA AL EJE DEL CILINDRO, CON LO QUE SE CONSIGUE UNA FORMA DE CONSTRUCCION ESBELTA.
Patent ES-2074408-T1 (ES)
Inventor: HEINRICH GUNTER DIPL-PHYS
IPC: B01D39/08
Filed: 1994-05-18
Abstract: The invention relates to filter material, in particular for producing tea bags, coffee bags or coffee filters, comprising an at least two-layer nonwoven web fabric or the like, at least one layer produced on a papermaking machine comprising natural fibres and one layer comprising synthetic fibres and which are shaped flat and arranged one above the other. According to the invention, the second layer comprising synthetic fibres contains a multiplicity of individual synthetic fibres which are applied in the heated state to the first layer comprising natural fibres and are fused both together and to the fibres of the first layer. The filter material has, in particular, the advantage that by applying the individual synthetic fibres to a layer of natural fibres a great number of pores or channels of the layer made of natural fibres is covered or sealed. It thus shows an extremely low particle loss since only a small number of continuous pores are present, an interlaced and enclosed filter material being created essentially by the arrangement of individual synthetic fibres on the layer of natural fibres which are furthermore fused with this layer.
Patent CY-1107601-T1 (CY)
Title: Κυλιομενο ξυραφακι και μεθοδος ξυρισματος
Inventor: KLUDJIAN DAVID J
IPC: B26B21/22
Filed: 2007-03-26
Abstract: Μία λαβή για ξυραφάκι (15,84,91), σύστημα ξυρίσματος και συσκευή ξυρίσματος (10,20,30,40,50,60,70,80,90,100), όπου ακριβής έλεγχος με την άκρη των δακτύλων, της κλίσης, γωνίας και πίεσης που ασκείται από τις μόνιμες ή αντικαταστάσιμες ξυριστικές λεπίδες μπορεί να ελεγχθεί με ακρίβεια μέσω της σταδιακής κίνησης μίας λαβής κυλινδρικής σε σχήμα δακτυλιδιού.
Patent CY-1107001-T1 (CY)
Inventor: FURUTA YOUSUKE
IPC: A61P31/12
Filed: 2007-11-12
Abstract: Nitrogen-containing heterocyclic carboxamide derivatives represented by the following general formula: <CHEM> wherein ring A is a substituted or unsubstituted pyrazine, pyrimidine, pyridazine or triazine ring; R<1> is O or OH; R<2> is a hydrogen atom, an acyl group or a substituted or unsubstituted carbamoylalkyl or carboxyalkyl group; and the broken line represents a single bond or a double bond; or salts thereof are useful for preventing and treating virus infections and especially influenza virus infections.
Patent CY-1108196-T1 (CY)
Inventor: AIANI MAURO
IPC: A61K9/28
Filed: 2008-07-14
Abstract: The present invention relates to oral pharmaceutical compositions with controlled and/or programmed release containing at least one active ingredient having antimicrobial and/or anti-infectious activity for the treatment of infections of the large intestine, in particular the colon.
Patent CY-1110807-T1 (CY)
Inventor: MALLARD CLAIRE
IPC: A61P17/00
Filed: 2010-09-30
Abstract: Solubilizing metronidazole comprises mixing an aqueous phase of metronidazole with glycolic niacinamide or its salts and at least two glycolic co-solvents, in the absence of cyclodextrin. Independent claims included for: (1) an aqueous metronidazole solution and obtained by the process; (2) an aqueous solution of metronidazole and niacinamide obtained by the process comprising at least two glycolic co-solvents; and (3) a pharmaceutical composition comprising the solution. ACTIVITY : Dermatological. MECHANISM OF ACTION : None given.
Patent CY-1115028-T1 (CY)
Title: Οργανικες ενωσεις
Inventor: BAETTIG URS
IPC: C07C311/48
Filed: 2014-04-14
Abstract: Η παρούσα εφεύρεση αναφέρεται στις ενώσεις του Χημικού τύπου (I) όπου οι Χ, R1, R2, R3, R4 και R5 ορίζονται στο παρόν, οι οποίες μπορούν να χρησιμοποιηθούν για την αντιμετώπιση των νοσημάτων που ανταποκρίνονται στους μεσολαβητές του CXCR2 υποδοχέα. Περιγράφονται επίσης οι φαρμακευτικές συνθέσεις που περιέχουν τις ενώσεις και οι διαδικασίες παρασκευής των ενώσεων αυτών.
Patent CY-1116917-T1 (CY)
Title: Αναλογα οξυντομοντουλινης
Inventor: CARRINGTON PAUL E
IPC: C07K14/605
Filed: 2014-12-18
Abstract: Περιγράφονται τα πεπτιδικά ανάλογα της οξυντομοντουλίνης (ΟΧΜ, γλυκαγόνη-37), τα οποία έχουν τροποποιηθεί ώστε να είναι ανθεκτικά στη διάσπαση και στην αδρανοποίηση από την διπεπτιδυλική πεπτιδάση IV (DPP-IV) και να αυξάνουν in vivo το χρόνο ημιζωής του πεπτιδικού αναλόγου, καθιστώντας παράλληλα ικανό το πεπτιδικό ανάλογο να δρα ως διπλός αγωνιστής των GLP-1/γλυκαγόνη (GCGR). Τα πεπτιδικά ανάλογα είναι χρήσιμα στη θεραπεία μεταβολικών διαταραχών, όπως διαβήτης και παχυσαρκία.
Patent CY-1116589-T1 (CY)
Title: Παραγωγο κυκλοπεντυλακρυλamιδιου
Inventor: FUKUDA YASUMICHI
IPC: A61K31/428
Filed: 2015-08-07
Abstract: Παρέχεται ένωση έχουσα υπογλυκαιμικό αποτέλεσμα. Η ένωση και φαρμακευτικώς αποδεκτό άλας αυτής είναι χρήσιμα για την θεραπεία ή την πρόληψη διαβήτη, παχυσαρκίας και των παρομοίων. Η ένωση αντιπροσωπεύεται με τον γενικό τύπο (1): (όπου R1 και R2 εκάστη ανεξαρτήτως είναι άτομο υδρογόνου, άτομο αλογόνου, άμινο ομάδα, υδροξύλ ομάδα, υδροξυάμινο ομάδα, νίτρο ομάδα, κύανο ομάδα, σουλφαμοΰλ ομάδα, C1 έως C6 αλκύλ ομάδα, C1 έως C6 αλκόξυ ομάδα, C1 έως C6 αλκυλσουλφονύλ ομάδα, C1 έως C6 αλκυλσουλφινύλ ομάδα, C1 έως C6 αλκυλσουλφονύλ ομάδα ή C1 έως C6 αλκόξυ-C1 έως C6 αλκυλσουλφονύλ ομάδα και Α είναι υποκατεστημένη ή μη-υποκατεστημένη ετεροαρύλ ομάδα).
Patent CY-1117673-T1 (CY)
Title: Ανασυνδυασμενα αντιγονα rsv
Inventor: BAUDOUX GUY JEAN MARIE FERNAND PIERRE
IPC: C07K14/135
Filed: 2016-06-21
Abstract: Η αποκάλυψη παρέχει ανασυνδυασμένα αντιγόνα αναπνευστικού συγκυτιακού ιού (RSV) και μεθόδους για κατασκευή και χρήση αυτών, που συμπεριλαμβάνουν ανοσογονικές συνθέσεις (π.χ., εμβόλια) για την θεραπεία ή/και πρόληψη μόλυνσης RSV.
Patent CY-1120335-T1 (CY)
Title: Εγχυτης και μεθοδος συναρμολογησης
Inventor: TAN-MALECKI FRANCISCA
IPC: A61M5/24
Filed: 2018-06-14
Abstract: Ένας εγχυτής μπορεί να περιλαμβάνει έναν περιέκτη που έχει ένα τοίχωμα με μια εσωτερική επιφάνεια και μια μονάδα στεγανοποίησης με μια εσωτερική επιφάνεια, όπου οι εσωτερικές επιφάνειες του τοιχώματος και της μονάδας στεγανοποίησης ορίζουν μια κλειστή αποστειρωμένη δεξαμενή γεμισμένη με ένα φάρμακο. Ο εγχυτής μπορεί επίσης να περιλαμβάνει ένα σύστημα χορήγησης υγρών το οποίο αποτελείται από μια καθαρή, χωρίς θηκάρι, άκαμπτη βελόνα περιέκτη η οποία έχει μια αιχμή που βρίσκεται μόνο εν μέρει μέσα στη μονάδα στεγανοποίησης κατά την κατάσταση φύλαξης και βρίσκεται διαμέσου της εσωτερικής επιφάνειας της μονάδας στεγανοποίησης μέσα στην αποστειρωμένη δεξαμενή στην κατάσταση χορήγησης. Επιπλέον, ο εγχυτής μπορεί να περιλαμβάνει έναν μηχανισμό ενεργοποίησης ο οποίος είναι προσαρμοσμένος ώστε να μετακινεί τη βελόνα περιέκτη από την κατάσταση φύλαξης στην κατάσταση χορήγησης.
Patent CY-1124467-T1 (CY)
Title: Περιτοναϊκο θεραπευτικο υγρο
Inventor: GRENTZMANN GUIDO
IPC: A61K31/05
Filed: 2021-08-13
Abstract: Περιτοναϊκό θεραπευτικό υγρό που περιλαμβάνει έναν ή περισσότερους παράγοντες ενίσχυσης βιοσυμβατότητας (BCA) που επιλέγονται από την ομάδα που αποτελείται από μια πολυφαινολική ένωση, έναν μεταβολίτη μιας πολυφαινολικής ένωσης που λαμβάνεται με μεταβολισμό στο ανθρώπινο ή ζωικό σώμα, ένα άλας ή έναν γλυκοζίτη μιας πολυφαινολικής ένωσης.
Patent CY-1124865-T1 (CY)
Title: Νεες ενωσεις
Inventor: PORRAS DE FRANCISCO ESTHER
IPC: C07D401/04
Filed: 2021-12-17
Abstract: Η εφεύρεση αφορά σε ενώσεις του Τύπου (Ι) και χρήση αυτών στη θεραπεία, για παράδειγμα στη θεραπεία μυκοβακτηριακών μολύνσεων ή στη θεραπεία ασθενειών που προκαλούνται με μυκοβακτηρίδιο, όπως φυματίωσης.
Patent GR-990300028-T1 (GR)
Title: Fluid flow resistance monitoring system
Inventor: BUTTERFIELD ROBERT D
IPC: A61M5/168
Filed: 1997-07-29
Abstract: Flow parameters in a fluid delivery assembly are determined by monitoring pressure responses and processing those responses along with information regarding the fluid flow. In one aspect, a processor controls the pump to pump flow quantities in accordance with a pseudorandom code. Portions of the resulting pressure signal sensed are then decoded in accordance with the pseudorandom code. An estimate of the equilibrium pressure is generated from the decoded pressure values, while a summation of the pressure samples is generated from the undecoded pressure signals. The resistance to fluid flow of the system is determined from the estimated equilibrium pressure and pressure summation. For low flow rates, a processor controls the pump to pump fluid in a series of fluid boluses, with each fluid bolus delivered in the beginning of a separate timeslot. The equilibrium pressure is measured at the end of each timeslot, and a summation of the pressure samples is generated from the pressure signals. For high flow rates, the pump is controlled to vary the flow rate and the change in pressure is divided by the change in flow to directly determine the resistance. A resistance display continuously displays the resistance of the system. The pseudorandom coding and decoding can be used to filter out pressure-response crosstalk caused by multiple fluid infusion segments feeding into a common line.
Patent HR-P20110030-T1 (HR)
Title: Production line for manufacturing of flat wood-based panels with a printed upper surface
Inventor: FRATI DANTE
IPC: B41J3/407
Filed: 2011-01-17
Abstract: A process for printing wood-based flat elements (10), comprising a preliminary step of graphic composition by means of an electronic processor and relative software, and a printing step. To print the wood-based flat elements (10) an ink-jet printer (12) of the single-pass type is used controlled by the electronic processor. Either the flat element (10) is maintained at rest and the printer (12) moves relative thereto during the printing operation, in order to print the entire surface thereof involved, or the flat element (10) and the printer move simultaneously, with the printer moving parallel to the surface of the flat element.
Patent HR-P20110967-T1 (HR)
Inventor: BLOMENHOFER HELMUT
IPC: G08G5/00
Filed: 2011-12-21
Abstract: Uređenje upravljanja zračnim prometom i/ili kontrole letenja zrakoplova (1, 2), koje obuhvaća barem jednu odašiljačku stanicu (3, 4) u zrakoplovu (1, 2), kojim se upravlja i/ili ga se kontrolira, te određeni broj prijemnih stanica (20) međusobno udaljenih jedna od druge koje su povezane na centar za upravljanje zračnim prometom i/ili za kontrolu letenja (11), u čemu barem jedna odašiljačka stanica (3, 4) zrakoplova (1, 2) kojim se upravlja i/ili ga se kontrolira, odašilje radiosignal (5, 6), barem jedna od prijemnih stanica (20) prima radio signal (5, 6) i barem dio podataka sadržanih u radiosignalu (5, 6) prosljeđuje centru za upravljanje zračnim prometom i/ili za kontrolu letenja (11) ili drugim organizacijama, naznačeno time, da je barem dio prijemnih stanica (20) konfiguriran kao satelitske prijemne stanice, tako da iste primaju 1090 MHz radiosignal (5, 6) iz odašiljačke stanice (3, 4), konfigurirane kao Mode S Extended Squitter zrakoplova (1, 2) kojim se upravlja i/ili ga se kontrolira i barem dio podataka sadržanih u njemu prosljeđuju putem radio transmisijskog linka (21, 25, 27) satelitskoj kontrolnoj stanici na tlu i dalje centru za upravljanje zračnim prometom i/ili za kontrolu letenja (11) ili drugim organizacijama. Patent sadrži još 13 patentnih zahtjeva.
Patent SI-1194468-T1 (SI)
Title: High-resilient polyurethane foams produced from polyether polyols
Inventor: HOFMANN JOERG
IPC: C08G101/00
Filed: 2000-06-06
Abstract: Flexible polyurethane foams are produced from a polyisocyanate and a polyether polyol which has been alkoxylated in the presence of a double metal cyanide catalyst and that has at least one ethylene oxide-propylene oxide mixed block.
Patent SI-1240142-T1 (SI)
Title: New modulators of dopamine neurotransmission
Inventor: ANDERSSON BENGT
IPC: A61P25/28
Filed: 2000-12-22
Abstract: New 3-substituted 4-(phenyl-N-alkyl)-piperazine and 4-(phenyl-N-alkyl)-piperidine compounds of Formula 1:   
wherein X N, CH, or C, however X may only be C when the compound comprises a double bond at the dotted line; R 1  is OSO 2 CF 3 , OSO 2 CH 3 , SOR 3 , SO 2 R 3 , COR 3 , NO 2 , or CONHR 3  and when X is CH or C R 1  may also be CF 3 , CN, F, Cl, Br, or I; R 2  is a C 1 -C 4  alkyl, an allyl, CH 2 SCH 3 , CH 2 CH 2 OCH 3 , CH 2 CH 2 CH 2 F, CH 2 CF 3 , 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, or -(CH 2 )-R 4 ; R 3  is a C 1 -C 3  alkyl, CF 3 , or N(R 2 ) 2 ; R 4  is a C 3 -C 6  cycloalkyl, 2-tetrahydrofurane or 3-tetra-hydrofurane, as well as pharmaceutically acceptable salts thereof are disclosed. 
Also pharmaceutical compositions comprising the above compounds and methods wherein the above compounds are used for treatment of disorders in the central nervous system are disclosed.
Patent SI-2432975-T1 (SI)
Title: Method for generating electrical energy, and use of a working substance
Inventor: BOZEK EWA
IPC: F01K25/00
Filed: 2010-04-15
Abstract: In a method for generating electrical energy by means of at least one low-temperature heat source (2), a VPT cyclic process (1, 10, 100) is carried out. Certain working substances are used to increase the efficiency of the VPT cyclic process.
Patent SI-2597187-T1 (SI)
Title: Drum-type washing machine
Inventor: TAGUCHI TOMOYUKI
IPC: D06F33/48
Filed: 2012-02-20
Abstract: This drum-type washing machine is configured to have a mode for selecting the detection axis that indicates the maximum value of the vibration value in the three-dimensional direction of a water tank (42) and that was detected by means of a vibration detecting unit (78) during a draining step, and for restarting the draining operation when the vibration value detected by means of the aforementioned detection axis surpasses a first threshold value set for each rotational speed range of a rotation drum (43) and is below a second threshold value. As a consequence, it is possible to detect abnormalities due to unbalance ahead of time and to safely stop the operation.
Patent SI-2970497-T1 (SI)
Title: Anti-tfpi antibody variants with differential binding across ph range for improved pharmacokinetics
Inventor: WANG ZHUOZHI
IPC: C07K16/00
Filed: 2014-03-14
Abstract: Antibodies are disclosed that bind to and inhibit the anti-coagulant function of TFPI and have a lower affinity for TFPI at pH 6.0 than at pH 7.4. The lower affinity at pH 6 improves circulating half-life (T½) due to reduced target mediated clearance, a process by which an antibody/antigen complex is endocytosed and trafficked to the lysosome where both components are degraded. The lower affinity at pH 6.0 results in disruption of the complex prior to lysosome targeting and allows for re-circulation of the antibody. Specific modifications to antibody binding by histidine residue substitution are disclosed along with methods of use.
Patent TR-200504909-T1 (TR)
Title: Düşük sürtünmeli, batık, asimetrik, deplasman tipi kaldırıcı cisim.
Inventor: LOUI STEVEN
IPC: B63B1/00
Filed: 2004-04-30
Abstract: Ana gövdesi deniz seviyesinde olan bir teknenin sualtı deplasman bölümleri olarak kullanılabilen düşük sürttünmeli sualtına batık kaldırıcı cisimler asimetriktir ve geliştirilmiş kaldırma kuvveti/sürtünme oranlarına sahiptir. Kaldırıcı cisimler, şekilleri yatay kesitte ve dikey olarak kaldırıcı cismin karşılıklı yüzlerinde farklı olan genel olarakparabolik eğrilerle oluşturulan dış yüzeylere sahiptir.
Patent TR-200601087-T1 (TR)
Title: Bir elyaf bağının mekanik olarak sıkıştırılması için düzenek
Inventor: STAHLECKER GERD
IPC: D01H5/72
Filed: 2004-07-17
Abstract: Bir elyaf bağının mekanik olarak sıkıştırılması için bir düzenek, bir besleme silindir çiftinin sıkıştırma yernin önüne tahsis edilmiş bir kompresyonelemanı ihtiva eder. Bu,oluk biçiminde, taşıma yönünde yanlamasına sivrileşen bir kompresyon yarığına sahip olup, bunun yarık tabanında elyaf bağ kayar bir şekilde iletilir.Kompresyon yarığı taşıma yönünde konveks bir şekilde tasarlanmış yarık tabanına sahiptir, bu,enine kesitinde tercihen V biçiminde tasarlanmıştır.Yarığın tabanı,kompresyon yarığının ucunda, kompresyon elemanının yine aynı şekilde konveks olarak tasarlanmış eyaf iletim yüzeyi üzerinden devam ettirilebilir.Bu elyaf iletim yüzeyi, besleme silindiri çiftinin bir besleme silindirine bastırılmış olabilir.
Patent DE-3650429-T2 (DE)
Inventor: KANEKO MASAKATSU C O SANKYO CO
IPC: C07D233/54
Filed: 1986-04-21
Granted: 1996-06-13
Abstract: New griseolic acid derivatives have various groups attached to the sugar part in place of the adenine group of griseolic acid itself. These groups are all purine derivatives or ring-opened purine analogs. The compounds are useful as inhibitors of phosphodiesterases. They may be prepared by replacing the adenine moiety of griseolic acid and/or dihydrodesoxygriseolic acid and/or by replacing other substituent groups.
Patent DE-3750630-T2 (DE)
Inventor: EPSTEIN ALAN L
IPC: C12P21/08
Filed: 1987-12-01
Granted: 1995-05-04
Abstract: Disclosed is a method for measuring the effectiveness of therapy intended to kill malignant cells in vivo in a mammal, comprising the steps of obtaining monoclonal antibody that is specific to an internal cellular component of the mammal but not to external cellular components, wherein the monoclonal antibody is labeled; contacting the labeled antibody with tissue of a mammal that has received therapy to kill malignant cells in vivo and determining the effectiveness of the therapy by measuring the binding of the labeled antibody to the internal cellular component. The internal cellular component is preferably insoluble intracellular antigen, and the label is preferably a radionuclide, a radiopaque material, or a magnetic resonance-enhancing material. Also disclosed is a method whereby the antibody to insoluble intracellular antigen is conjugated to an antineoplastic agent, so that upon administration of the antibody-antineoplastic agent conjugate, antineoplastic agent may be delivered to the tumor. Also disclosed are antibodies for use with the foregoing methods.
Patent DE-3752120-T2 (DE)
Inventor: DRENT EIT
IPC: C08G67/00
Filed: 1987-10-29
Granted: 1998-01-29
Abstract: Copolymers of carbon monoxide with at least two α-olefinically unsaturated compounds, whicha) have been prepared by polymerization of carbon monoxide with one or more monomers (A) of the general formula (CH₂=CR₁)-R₂ and with one or more monomers (B) chosen from the group formed by compounds of the general formulae (CH₂=CR₁)N(R₂)COR₄ and (CH₂=CR₁)CON(R₂)R₄, wherein R₁, R₂ and R₄ are hydrogen atoms and/or hydrocarbyl groups,b) have a linear structure, andc) are made up of units of the general formula -CO-(A')- and units of the general formula -CO-(B')-, wherein A' and B' represent monomer units originating, respectively, in monomers A and B used.